ADSC-Exo-bFGF promotes skin wound healing and correlates with the PI3K/AKT signaling pathway activation
In vivo results confirmed that compared with control groups, ADSC-Exo-bFGF treatment significantly accelerated skin wound healing, reduced inflammatory infiltration, and enhanced collagen deposition, exerting better therapeutic effects than unmodified ADSC-derived exosomes.